This inventor holds 4 USPTO granted patents. Top assignee: Ishihara Sangyo Kaisha, Ltd.. Active years: 1993-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993-1996
Title: Syuichi Yotsuya: Innovator in Pharmaceutical Chemistry
Introduction
Syuichi Yotsuya is a prominent inventor based in Kusatsu, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 4 patents to his name, Yotsuya's work has the potential to impact the treatment of various diseases.
Latest Patents
Yotsuya's latest patents focus on diaminotrifluoromethylpyridine derivatives and their production processes. One of his notable inventions is a method for treating rheumatoid arthritis using a diaminotrifluoromethylpyridine derivative. This compound is defined by a specific formula that includes various substituents, allowing for a range of applications in therapeutic settings. His innovative approach to these derivatives showcases his expertise in medicinal chemistry.
Career Highlights
Syuichi Yotsuya is currently associated with Ishihara Sangyo Kaisha, Ltd., where he continues to advance his research and development efforts. His work at this esteemed company has allowed him to collaborate with other talented professionals in the field. Yotsuya's dedication to innovation has positioned him as a key figure in pharmaceutical research.
Collaborations
Throughout his career, Yotsuya has worked alongside notable colleagues such as Takahiro Haga and Hideo Sugi. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in pharmaceutical chemistry.
Conclusion
Syuichi Yotsuya's contributions to the field of pharmaceutical chemistry are noteworthy and impactful. His innovative patents and collaborations reflect his commitment to advancing medical treatments. As he continues his work, Yotsuya remains a significant figure in the realm of pharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile